{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:10:52Z","timestamp":1789157452592,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573336"],"award-info":[{"award-number":["82573336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004317","name":"Shihezi University","doi-asserted-by":"publisher","award":["ZZZC2023026"],"award-info":[{"award-number":["ZZZC2023026"]}],"id":[{"id":"10.13039\/501100004317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cellsig.2026.112759","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:54:48Z","timestamp":1784876088000},"page":"112759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrative multi-omics profiling reveals DRG1 promotes hepatocellular carcinoma via c-Myc phosphorylation and facilitates lenvatinib resistance"],"prefix":"10.1016","volume":"147","author":[{"given":"Peng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengtong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingming","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2026.112759_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2026.112759_bb0010","first-page":"1","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112759_bb0015","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1053\/j.gastro.2021.06.008","article-title":"Evidence-based management of hepatocellular carcinoma: systematic review and meta-analysis of randomized controlled trials (2002\u22122020)","volume":"161","author":"Haber","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112759_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.109723","article-title":"Dynamic ALBI score and FIB-4 index trends to predict complications after resection of hepatocellular carcinoma: a K-means clustering approach","volume":"51","author":"Akabane","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.cellsig.2026.112759_bb0025","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429310703240823045808","article-title":"Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation","volume":"17","author":"Sensi","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"10360","key":"10.1016\/j.cellsig.2026.112759_bb0030","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112759_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","article-title":"Integrative bioinformatics analysis for targeting hub genes in hepatocellular carcinoma treatment","volume":"26","author":"Gudivada","year":"2025","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.cellsig.2026.112759_bb0040","article-title":"Upregulation of miR-3130-5p enhances hepatocellular carcinoma growth by suppressing ferredoxin 1\u202f: miR-3130-5p enhances HCC growth via inhibiting FDX1","volume":"17","author":"Xu","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112759_bb0045","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","article-title":"Association between higher expression of Vav1 in hepatocellular carcinoma and unfavourable clinicopathological features and prognosis","volume":"31","author":"Ye","year":"2024","journal-title":"Protein Pept. Lett."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112759_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183308","article-title":"Structural insights into the regulation mechanism of small GTPases by GEFs","volume":"24","author":"Toma-Fukai","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.cellsig.2026.112759_bb0055","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1146\/annurev-biochem-062708-134043","article-title":"Structure-function relationships of the G domain, a canonical switch motif","volume":"80","author":"Wittinghofer","year":"2011","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112759_bb0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/jmbi.2001.5378","article-title":"Classification and evolution of P-loop GTPases and related ATPases","volume":"317","author":"Leipe","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112759_bb0065","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/nar\/gkq898","article-title":"The highly conserved eukaryotic DRG factors are required for efficient translation in a manner redundant with the putative RNA helicase Slh1","volume":"39","author":"Daugeron","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112759_bb0070","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/EC.00356-08","article-title":"Saccharomyces cerevisiae Rbg1 protein and its binding partner Gir2 interact on polyribosomes with Gcn1","volume":"8","author":"Wout","year":"2009","journal-title":"Eukaryot. Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112759_bb0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3892\/mmr.2015.4565","article-title":"MicroRNA-1915-3p prevents the apoptosis of lung cancer cells by downregulating DRG2 and PBX2","volume":"13","author":"Xu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112759_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124094","article-title":"Identification of DRG-1 as a melanoma-associated antigen recognized by CD4+ Th1 cells","volume":"10","author":"Kiniwa","year":"2015","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112759_bb0085","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200282","article-title":"m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma","volume":"40","author":"Ling","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cellsig.2026.112759_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1459057","article-title":"Cell cycle checkpoint revolution: targeted therapies in the fight against malignant tumors","volume":"15","author":"Song","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112759_bb0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrc3984","article-title":"MYC: connecting selective transcriptional control to global RNA production","volume":"15","author":"Kress","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112759_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112759_bb0105","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/s41467-023-38160-x","article-title":"DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112759_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0959-437X(00)00174-X","article-title":"Functional significance of histone deacetylase diversity","volume":"11","author":"Khochbin","year":"2001","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112759_bb0115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3350\/cmh.2022.0391","article-title":"Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity","volume":"29","author":"Iwamoto","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cellsig.2026.112759_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118642","article-title":"Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib","volume":"264","author":"Zhao","year":"2021","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112759_bb0125","first-page":"1993","article-title":"Overexpression of long non-coding RNA cancer susceptibility 11 is involved in the development of chemoresistance to carboplatin in hepatocellular carcinoma","volume":"19","author":"Liu","year":"2020","journal-title":"Oncol. Lett."},{"issue":"Suppl. 3","key":"10.1016\/j.cellsig.2026.112759_bb0130","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.21037\/atm.2019.06.12","article-title":"New insights in predictive determinants of the tumor immune microenvironment for immune checkpoint inhibition: a never ending story?","volume":"7","author":"Eckstein","year":"2019","journal-title":"Ann Transl Med"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112759_bb0135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1387\/ijdb.8179998","article-title":"Expression of GTP-binding protein gene drg during Xenopus laevis development","volume":"37","author":"Kumar","year":"1993","journal-title":"Int. J. Dev. Biol."},{"issue":"16","key":"10.1016\/j.cellsig.2026.112759_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169137","article-title":"Stabilization of the c-Myc protein via the modulation of threonine 58 and serine 62 phosphorylation by the disulfiram\/copper complex in oral cancer cells","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.cellsig.2026.112759_bb0145","doi-asserted-by":"crossref","first-page":"9085","DOI":"10.1073\/pnas.0402770101","article-title":"The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation","volume":"101","author":"Welcker","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112759_bb0150","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.emboj.7600217","article-title":"Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7","volume":"23","author":"Yada","year":"2004","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112759_bb0155","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014365","article-title":"MYC degradation","volume":"4","author":"Farrell","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"13","key":"10.1016\/j.cellsig.2026.112759_bb0160","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/onc.2016.344","article-title":"HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer","volume":"36","author":"Stojanovic","year":"2017","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112759_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028103","article-title":"Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1\/S cell cycle proteins","volume":"6","author":"Noh","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.cellsig.2026.112759_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107518","article-title":"Lansoprazole as a potent HDAC2 inhibitor for treatment of colorectal cancer: an in-silico analysis and experimental validation","volume":"166","author":"Khadempar","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112759_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104069","article-title":"New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma","volume":"29","author":"Fan","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cellsig.2026.112759_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100976","article-title":"Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression","volume":"69","author":"Wang","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.cellsig.2026.112759_bb0185","article-title":"Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer","volume":"16","author":"Dong","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112759_bb0190","article-title":"Organoids in cancer research and regenerative medicine: current status, challenges, and future prospects","volume":"7","author":"Li","year":"2026","journal-title":"MedComm (2020)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112759_bb0195","first-page":"33","article-title":"Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy","volume":"5","author":"Guo","year":"2024","journal-title":"Biomater. Transl."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112759_bb0200","doi-asserted-by":"crossref","DOI":"10.36922\/OR026020002","article-title":"Integrating patient-derived organoids and multi-omics to decode spatiotemporal therapeutic resistance","volume":"2","author":"Gao","year":"2026","journal-title":"Organoid Research"}],"updated-by":[{"DOI":"10.1016\/j.cellsig.2026.112798","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000}},{"DOI":"10.1016\/j.cellsig.2026.112798","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000}}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600416X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600416X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:46:33Z","timestamp":1789155993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682600416X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S089865682600416X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112759","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative multi-omics profiling reveals DRG1 promotes hepatocellular carcinoma via c-Myc phosphorylation and facilitates lenvatinib resistance","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112759"}}